US Medicare Inflation Rebate: Limited Relief For Drugs In Shortage
CMS is updating its guidance for manufacturers on calculating inflation penalties enacted as part of the Inflation Reduction Act. The agency is outlining a policy to provide some rebate relief for drugs in shortage – but only limited relief for a short time.
